Drug intelligence / Profile preview

paracetamol + tramadol + ondansetron

Development stage
Unknown
Lead developer
Grünenthal
Modality
Small Molecules
Administration
Oral, Intravenous, Intramuscular, Rectal
01

Overview

This is a combination of three separate medications: paracetamol (acetaminophen), tramadol, and ondansetron. Paracetamol and tramadol together form a fixed-dose combination analgesic (often marketed as Ultracet) for moderate to severe pain, while ondansetron is a 5-HT3 receptor antagonist used to manage nausea and vomiting. This three-drug combination may be used in clinical practice, particularly for post-operative pain management where pain control and prevention of nausea/vomiting are both important. ## Medication Components **Paracetamol (Acetaminophen)**: An analgesic with unknown exact mechanism but believed to work through central and peripheral effects. **Tramadol**: A centrally acting synthetic opioid analgesic and serotonin-norepinephrine reuptake inhibitor (SNRI) that has about 1/10th the potency of morphine. It works through multiple mechanisms including μ-opioid receptor agonism and effects on serotonin and norepinephrine. **Ondansetron**: A serotonin (5-HT3) receptor antagonist primarily used to treat nausea and vomiting. ## Interactions and Clinical Considerations There are potential interactions between these medications that clinicians should be aware of: 1. **Tramadol and Ondansetron Interaction**: Some studies suggest there may be a pharmacodynamic interaction between tramadol and ondansetron. There are conflicting findings about whether ondansetron reduces the analgesic efficacy of tramadol[2]. Some research indicates that ondansetron might block tramadol's effects, potentially increasing tramadol consumption in patients[2], while other studies found no significant change in tramadol consumption when co-administered with ondansetron[2]. 2. **Paracetamol and Ondansetron Interaction**: Interestingly, one study found that co-administration of paracetamol and ondansetron actually increased the analgesic effect of paracetamol, contrary to earlier findings with other 5-HT3 antagonists[5]. This study recommended the co-administration of paracetamol and ondansetron for effective postoperative pain management[5]. 3. **Combined Use in Clinical Practice**: The tramadol-paracetamol combination (Ultracet) is indicated for the symptomatic treatment of moderate to severe pain[3]. Ondansetron may be prescribed alongside this combination to manage potential nausea and vomiting, which are common side effects of tramadol. The combination of these three medications requires careful consideration of potential interactions and side effects. Healthcare providers should monitor patients closely when these medications are used together, particularly for efficacy of pain relief and any adverse effects.

02

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)HTR3A (5-hydroxytryptamine receptor 3A)HTR2C (5-hydroxytryptamine 2C receptor)PGHS-1 (Prostaglandin G/H Synthase 1)HTR1B (5-Hydroxytryptamine Receptor 1B)KOR (Kappa opioid receptor)ADRA1A (α1A)SERT (Sodium-dependent serotonin transporter)NET (Norepinephrine Transporter)DOR (Opioid Receptor Delta 1)MOR (Mu opioid receptor)

Beyond the preview

Go deeper on paracetamol + tramadol + ondansetron.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on paracetamol + tramadol + ondansetron.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call